Industry news
MESOBLAST FINANCIAL YEAR END RESULTS
In order to access this content you must be logged in and have a subscription to Pharmalicensing Intelligence.
Pharmalicensing Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Company details
If you want to find out more about the company visit Mesoblast profile.
Related reports
Related news
Latest News
- Market Update
- Financial Results for The First Half Of 2010: Programs On Track, Decrease In Operating Loss, Controlled Burn Rate And Strong Cash Position
- Monsanto Projects Solid Conclusion of Fiscal Year
- Pacgen Reports First Quarter Financial Results
- Financial Results H1 2010
- Preliminary Final Report for the year ended 30 June 2010
- MESOBLAST FINANCIAL YEAR END RESULTS
- EntreMed Reports Second Quarter 2010 Financial Results
- Hana Biosciences Reports Second Quarter 2010 Financial Results
- NuSep Investor Presentations
- More news... | RSS Feed...
Most Viewed
Preliminary Final Report for the year ended 30 June 2010
Monsanto Projects Solid Conclusion of Fiscal Year
Hana Biosciences Reports Second Quarter 2010 Financial Results
MESOBLAST FINANCIAL YEAR END RESULTS
Pacgen Reports First Quarter Financial Results
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us